Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol

BACKGROUND: Acute respiratory distress syndrome (ARDS) in humans is caused by an unchecked proinflammatory response that results in diffuse and severe lung injury, and it is associated with a mortality rate of 35 to 45%. Mesenchymal stromal cells (MSCs; ‘adult stem cells’) could represent a promisin...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Lalu, Manoj M, Moher, David, Marshall, John, Fergusson, Dean, Mei, Shirley HJ, Macleod, Malcolm, Griffin, Gilly, Turgeon, Alexis F, Rudnicki, Michael, Fishman, Jason, Avey, Marc T, Skidmore, Becky, Grimshaw, Jeremy M, Stewart, Duncan J, Singh, Kavita, McIntyre, Lauralyn
التنسيق: Artigo
اللغة:Inglês
منشور في: BioMed Central 2014
الموضوعات:
Protocol
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4046388/
https://ncbi.nlm.nih.gov/pubmed/24887266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2046-4053-3-48
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة